Higher S100B levels predict persistently elevated anhedonia with escitalopram monotherapy versus antidepressant combinations: Findings from CO-MED trial

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Higher S100B levels predict persistently elevated anhedonia with escitalopram monotherapy versus antidepressant combinations: Findings from CO-MED trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds